House Advances Bills Targeting Pharma IP Practices
The House Judiciary Committee has cleared legislation aimed at cutting drug prices by outlawing a pharmaceutical industry practice known as "product hopping," as well as streamlining the patent process so biosimilars...To view the full article, register now.
Already a subscriber? Click here to view full article